Pharma

Your Article Summary

See Latest Articles

ORENCIA Demonstrated Sustained Clinical Response in a Study of Adult Patients with Moderate to Severe Early Rheumatoid Arthritis
Bristol Myers-Squibb Company, 10/20/09

Bristol–Myers Squibb Company announced two–year results of a study that supports use of ORENCIA for methotrexate–naive patients with moderate to severe rheumatoid arthritis of less than or equal to two years duration.

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09

Huntington Hill Installs Toshiba Aquilion Premium CT
Imaging Economics, 11/25/09

Baytubes carbon nanotubes in marine coatings help reduce frictional resistance
BayNews International, 11/24/09

 See all of Medical Devices/Products

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09

Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects
BayNews International, 11/25/09

Reports Rate Ambulatory EHR Software
HealthDataManagement, 11/25/09

 See all of Research & Development